Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961074 | PMC |
| http://dx.doi.org/10.1113/jphysiol.2013.268318 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rebuttal to Correspondence on "Suspect and Nontarget Screening for Contaminants of Emerging Concern in an Urban Estuary".
Environ Sci Technol
November 2022
Center for Urban Waters, Tacoma, Washington 98421, United States.
Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase.
Expert Opin Ther Targets
May 2017
a Department of Biochemistry and Molecular Biology , Wayne State University School of Medicine, Detroit , MI , USA.
Methionine sulfoximine (MSO), a well-characterized inhibitor of glutamine synthetase, displays significant therapeutic benefits in animal models for several human diseases. This amino acid might therefore be a viable candidate for drug development to treat diseases for which there are few effective therapies. Areas covered: We describe the effects of MSO on brain swelling occurring in overt hepatic encephalopathy resulting from liver failure, the effects of MSO on excitotoxic damage involved in amyotrophic lateral sclerosis (ALS) or resulting from stroke, and the effects of MSO on a model for an inflammatory immune response involved in a range of diseases.
View Article and Find Full Text PDFRebuttal from Peter D. Wagner.
J Physiol
September 2015
Department of Medicine, Division of Physiology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0623, USA.
Rebuttal from Drs Schröder-Bäck and Martakis.
Chest
October 2015
Department of International Health, CAPHRI-School of Public Health and Primary Care, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands; Children's and Adolescents' Hospital, University Hospital of Cologne, Cologne, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!